Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00104611 | Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive Disorder | PHASE3 | COMPLETED | 286 | — | — | Jan 1, 2004 | Nov 1, 2005 | Sep 20, 2013 | 13 | United States |
| Arm | Type | Description |
|---|---|---|
| TMS | ACTIVE_COMPARATOR | Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment 5 days/week for up to 6 weeks |
| Placebo | PLACEBO_COMPARATOR | Treatment 5 days/week for up to 6 weeks |
| Name | Type | Description |
|---|---|---|
| Repetitive Transcranial Magnetic Stimulation | DEVICE | - |
Inclusion Criteria: * Primary diagnosis by DSM-IV criteria for Major Depressive Episode, single or recurrent episode as confirmed by the Structured Clinical Interview for the DSM-IV (SCID-IV), with the additional stipulation of a duration for this episode of greater than or equal to 4 weeks and CGI...